|
EP0970095B1
(en)
*
|
1997-03-07 |
2003-10-29 |
Metabasis Therapeutics, Inc. |
Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase
|
|
WO1998039344A1
(en)
*
|
1997-03-07 |
1998-09-11 |
Metabasis Therapeutics, Inc. |
Novel purine inhibitors of fructose-1,6-bisphosphatase
|
|
WO1999045016A2
(en)
|
1998-03-06 |
1999-09-10 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
BR9913532A
(pt)
*
|
1998-09-09 |
2001-10-02 |
Metabasis Therapeutics Inc |
Novos inibidores heteroaromáticos de frutose 1,6-bifosfatase
|
|
EP1391457B1
(de)
|
1998-11-03 |
2013-12-25 |
AbbVie Deutschland GmbH & Co KG |
Substituierte 2-Phenylbenzimidazole und deren Verwendung als PARP Inhibitoren
|
|
US6756360B1
(en)
|
1998-12-24 |
2004-06-29 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
|
DK1143955T3
(da)
*
|
1998-12-24 |
2005-11-14 |
Metabasis Therapeutics Inc |
En kombination af FBPase-inhibitorer og insulinsensibiliseringsmidler til behandling af diabetes
|
|
HUP0200260A3
(en)
*
|
1999-03-05 |
2002-11-28 |
Metabasis Therapeutics Inc San |
Novel phosphorus-containing prodrugs, their preparation and their use
|
|
US7205404B1
(en)
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
|
WO2001018013A1
(en)
*
|
1999-09-08 |
2001-03-15 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
|
IL149887A0
(en)
*
|
1999-12-22 |
2002-11-10 |
Metabasis Therapeutics Inc |
Novel bisamidate phosphonate prodrugs
|
|
AU2006202624B2
(en)
*
|
1999-12-22 |
2008-08-14 |
Metabasis Therapeutics, Inc. |
Novel bisamidate phosphonate prodrugs
|
|
WO2001052825A2
(en)
|
2000-01-21 |
2001-07-26 |
Novartis Ag |
Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
|
|
US6919322B2
(en)
*
|
2000-03-08 |
2005-07-19 |
Metabasis Therapeutics, Inc. |
Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors
|
|
US7563774B2
(en)
*
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
|
KR100854851B1
(ko)
*
|
2000-07-06 |
2008-08-27 |
메타베이시스 테라퓨틱스, 인크. |
당뇨병 치료에 유용한 ＦＢＰａｓｅ 억제제와 항당뇨제의조합물
|
|
JP4332496B2
(ja)
*
|
2002-05-13 |
2009-09-16 |
メタバシス・セラピューティクス・インコーポレイテッド |
Ｐｍｅａおよびｐｍｐａ環生成合成
|
|
JP4476811B2
(ja)
|
2002-05-13 |
2010-06-09 |
メタバシス・セラピューティクス・インコーポレイテッド |
Ｐｍｅａおよびそのアナログの新規ホスホン酸系プロドラッグ
|
|
DE60329211D1
(de)
*
|
2002-10-31 |
2009-10-22 |
Metabasis Therapeutics Inc |
Cytarabin-monophosphate prodrugs
|
|
US7829552B2
(en)
|
2003-11-19 |
2010-11-09 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing thyromimetics
|
|
US7129049B2
(en)
*
|
2003-12-22 |
2006-10-31 |
Regents Of The University Of Minnesota |
Method of detecting equine glycogen storage disease IV
|
|
CN1964967B
(zh)
|
2004-06-08 |
2014-04-16 |
症变治疗公司 |
路易斯酸介导的环状酯的合成
|
|
KR20070053764A
(ko)
*
|
2004-08-18 |
2007-05-25 |
메타베이시스 테라퓨틱스, 인크. |
프럭토스 1,6-비스포스파타제의 신규한 티아졸 억제제들
|
|
US7728026B2
(en)
|
2005-04-11 |
2010-06-01 |
Abbott Laboratories, Inc. |
2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
TW200720255A
(en)
*
|
2005-07-13 |
2007-06-01 |
Taiho Pharmaceutical Co Ltd |
Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
|
|
EP1752450A1
(en)
|
2005-08-01 |
2007-02-14 |
Merck Sante |
Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
|
|
CN102935081B
(zh)
|
2005-09-14 |
2015-03-04 |
武田药品工业株式会社 |
用于治疗糖尿病的二肽基肽酶抑制剂
|
|
EP1966157B1
(en)
|
2005-11-15 |
2010-03-24 |
Abbott Laboratories |
Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
|
|
CN101511821B
(zh)
|
2006-05-02 |
2013-07-17 |
Abbvie公司 |
取代的1h-苯并咪唑-4-羧酰胺类化合物是有效的parp抑制剂
|
|
US8466096B2
(en)
*
|
2007-04-26 |
2013-06-18 |
Afton Chemical Corporation |
1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
|
|
US8067613B2
(en)
|
2007-07-16 |
2011-11-29 |
Abbott Laboratories |
Benzimidazole poly(ADP ribose)polymerase inhibitors
|
|
EP2058308A1
(fr)
|
2007-11-12 |
2009-05-13 |
Merck Sante |
Dérivés de benzimidazoledihydrothiadiazinone comme inhibiteurs de fructose-1,6-biphosphatase et compositions pharmaceutiques les contenant.
|
|
ES2523720T3
(es)
|
2008-04-28 |
2014-12-01 |
Janssen Pharmaceutica, N.V. |
Benzoimidazoles como inhibidores de prolilhidroxilasa
|
|
AU2009296820B2
(en)
|
2008-09-26 |
2014-03-20 |
Merck Sharp & Dohme Llc |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
CA2741125A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
JO2870B1
(en)
|
2008-11-13 |
2015-03-15 |
ميرك شارب اند دوهم كورب |
Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes
|
|
US8759539B2
(en)
|
2008-11-17 |
2014-06-24 |
Merck Sharp & Dohme Corp. |
Substituted bicyclic amines for the treatment of diabetes
|
|
WO2010083199A1
(en)
|
2009-01-19 |
2010-07-22 |
Abbott Laboratories |
Benzthiazole inhibitors of poly(adp-ribose)polymerase
|
|
US20120046364A1
(en)
|
2009-02-10 |
2012-02-23 |
Metabasis Therapeutics, Inc. |
Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
|
|
EP2805951B1
(en)
|
2009-03-20 |
2018-03-14 |
Metabasis Therapeutics, Inc. |
Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
EP2464228B1
(en)
|
2009-08-13 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
BR112012004335A8
(pt)
|
2009-09-02 |
2016-06-21 |
Merck Sharp & Dohme |
Composto, composição farmacêutica, e, uso do composto.
|
|
WO2011041293A1
(en)
|
2009-09-30 |
2011-04-07 |
Takeda Pharmaceutical Company Limited |
Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
|
|
US8802695B2
(en)
|
2010-02-03 |
2014-08-12 |
Takeda Pharmaceutical Company Limited |
Apoptosis signal-regulating kinase 1 inhibitors
|
|
WO2011103256A1
(en)
|
2010-02-22 |
2011-08-25 |
Merck Sharp & Dohme Corp. |
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
CA2786314A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2011146358A1
(en)
|
2010-05-21 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
WO2012024183A1
(en)
|
2010-08-18 |
2012-02-23 |
Merck Sharp & Dohme Corp. |
Spiroxazolidinone compounds
|
|
EP3170813B1
(en)
|
2010-10-06 |
2018-12-12 |
GlaxoSmithKline LLC |
Benzimidazole derivatives as pi3 kinase inhibitors
|
|
EP3243385B1
(en)
|
2011-02-25 |
2021-01-13 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
AU2012240122B2
(en)
|
2011-04-08 |
2016-08-25 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
US20140088124A1
(en)
|
2011-06-02 |
2014-03-27 |
Robert J. DeVita |
Imidazole derivatives
|
|
CA2838079A1
(en)
|
2011-06-16 |
2012-12-20 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
|
|
US9422266B2
(en)
|
2011-09-30 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
EP2771000B1
(en)
|
2011-10-24 |
2016-05-04 |
Merck Sharp & Dohme Corp. |
Substituted piperidinyl compounds useful as gpr119 agonists
|
|
ES2574262T3
(es)
|
2011-10-25 |
2016-06-16 |
Janssen Pharmaceutica, N.V. |
Formulaciones de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico
|
|
WO2013068328A1
(en)
|
2011-11-07 |
2013-05-16 |
Intervet International B.V. |
Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors
|
|
WO2013068439A1
(en)
|
2011-11-09 |
2013-05-16 |
Intervet International B.V. |
4-amino-5-oxo-7,8-dihydropyrimido[5, 4 -f] [1, 4] oxazepine compounds as dgat1 inhibitors
|
|
JP6101279B2
(ja)
|
2011-11-15 |
2017-03-22 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｇｐｒ１１９アゴニストとして有用な置換シクロプロピル化合物
|
|
US9073930B2
(en)
|
2012-02-17 |
2015-07-07 |
Merck Sharp & Dohme |
Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
WO2013155600A1
(en)
|
2012-04-16 |
2013-10-24 |
Kaneq Pharma |
Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors
|
|
EP2874622A4
(en)
|
2012-07-23 |
2015-12-30 |
Merck Sharp & Dohme |
TREATMENT OF DIABETES WITH DIPEPTIDYLPEPTIDASE IV INHIBITORS
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
ES2755087T3
(es)
|
2012-08-22 |
2020-04-21 |
Merck Sharp & Dohme |
Derivados de benzimidazol hexahidrofuro[3,2-b]furano útiles como activadores de proteína cinasa activada por AMP
|
|
WO2014031517A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel azabenzimidazole tetrahydrofuran derivatives
|
|
US9290517B2
(en)
|
2012-08-22 |
2016-03-22 |
Merck Sharp & Dohme Corp. |
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
|
|
WO2014031445A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel benzimidazole tetrahydropyran derivatives
|
|
WO2014031465A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel azabenzimidazole tetrahydropyran derivatives
|
|
WO2014031441A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel benzimidazole tetrahydrofuran derivatives
|
|
EP2931734B1
(en)
|
2012-12-17 |
2020-12-02 |
Merck Sharp & Dohme Corp. |
Novel glucokinase activator compounds, compositions containing such compounds, and methods of treatment
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
ES2747973T3
(es)
|
2013-11-15 |
2020-03-12 |
Merck Sharp & Dohme |
Compuestos tricíclicos antidiabéticos
|
|
WO2015089809A1
(en)
|
2013-12-19 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Antidiabetic substituted heteroaryl compounds
|
|
EP3097101B1
(en)
|
2014-01-24 |
2020-12-23 |
Merck Sharp & Dohme Corp. |
Isoquinoline derivatives as mgat2 inhibitors
|
|
CA2937548C
(en)
|
2014-02-13 |
2022-10-25 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and their uses
|
|
WO2015176267A1
(en)
|
2014-05-22 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2016003812A1
(en)
|
2014-07-02 |
2016-01-07 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and uses therof
|
|
US10968193B2
(en)
|
2014-08-08 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
US10100042B2
(en)
|
2014-08-08 |
2018-10-16 |
Merck Sharp & Dohme Corp. |
[5,6]—fused bicyclic antidiabetic compounds
|
|
WO2016022448A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
EP3825324A1
(en)
|
2014-10-24 |
2021-05-26 |
Merck Sharp & Dohme Corp. |
Co-agonists of the glucagon and glp-1 receptors
|
|
JP6722175B2
(ja)
|
2014-10-31 |
2020-07-15 |
エヌジーエム バイオファーマシューティカルズ インコーポレイテッド |
代謝障害を処置するための組成物及びその使用方法
|
|
TW201625635A
(zh)
|
2014-11-21 |
2016-07-16 |
默沙東藥廠 |
作為可溶性鳥苷酸環化酶活化劑之三唑并吡基衍生物
|
|
EP3078378B1
(en)
|
2015-04-08 |
2020-06-24 |
Vaiomer |
Use of factor xa inhibitors for regulating glycemia
|
|
WO2016191334A1
(en)
|
2015-05-27 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators
|
|
EP3310782B1
(en)
|
2015-05-28 |
2021-12-01 |
Merck Sharp & Dohme Corp. |
Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators
|
|
EP3359191A4
(en)
|
2015-10-05 |
2019-05-29 |
Merck Sharp & Dohme Corp. |
ANTIBODY PEPTIDE CONJUGATES WITH AGONISTEACTIVITY ON GLUCAGON RECEPTORS AND GLUCAGON-LIKE PEPTIDE-1
|
|
EP3383868B1
(en)
|
2015-11-30 |
2022-10-05 |
Merck Sharp & Dohme LLC |
Aryl sulfonamides as blt1 antagonists
|
|
WO2017107052A1
(en)
|
2015-12-22 |
2017-06-29 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase stimulators
|
|
WO2017197555A1
(en)
|
2016-05-16 |
2017-11-23 |
Merck Sharp & Dohme Corp. |
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators
|
|
WO2017201683A1
(en)
|
2016-05-25 |
2017-11-30 |
Merck Sharp & Dohme Corp. |
Substituted tetrahydroisoquinoline compounds useful as gpr120 agonists
|
|
US10414774B2
(en)
|
2016-08-15 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
|
|
WO2018034917A1
(en)
|
2016-08-15 |
2018-02-22 |
Merck Sharp & Dohme Corp. |
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
|
|
US11008313B2
(en)
|
2016-09-20 |
2021-05-18 |
Merck Sharp & Dohme Corp. |
Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders
|
|
CN109963561A
(zh)
|
2016-11-18 |
2019-07-02 |
默沙东公司 |
可用作二酰基甘油酯o-酰基转移酶2的抑制剂的吲哚衍生物
|
|
CA3043203A1
(en)
|
2016-11-18 |
2018-05-24 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
|
|
WO2018107415A1
(en)
|
2016-12-15 |
2018-06-21 |
Merck Sharp & Dohme Corp. |
Hydroxy isoxazole compounds useful as gpr120 agonists
|
|
CA3087932A1
(en)
|
2018-01-09 |
2019-07-18 |
Ligand Pharmaceuticals, Inc. |
Acetal compounds and therapeutic uses thereof
|
|
JOP20190150A1
(ar)
|
2018-06-21 |
2019-12-21 |
Merck Sharp & Dohme |
مركبات مناهضة لـ pcsk9
|
|
US12281109B2
(en)
|
2019-04-04 |
2025-04-22 |
Merck Sharp & Dohme Llc |
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
|
|
TW202123960A
(zh)
|
2019-08-30 |
2021-07-01 |
美商默沙東藥廠 |
Pcsk9拮抗劑化合物
|
|
EP3842061A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled triazole co-agonists of the glucagon and glp-1 receptors
|
|
EP3842060A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled lactam co-agonists of the glucagon and glp-1 receptors
|
|
EP3842449A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled olefin co-agonists of the glucagon and glp-1 receptors
|
|
WO2021236401A1
(en)
|
2020-05-18 |
2021-11-25 |
Merck Sharp & Dohme Corp. |
Novel diacylglyceride o-acyltransferase 2 inhibitors
|
|
JP7604636B2
(ja)
|
2020-10-08 |
2024-12-23 |
メルク・シャープ・アンド・ドーム・エルエルシー |
新規なジアシルグリセリドｏ－アシルトランスフェラーゼ２阻害剤としてのベンゾイミダゾロン誘導体の製造
|
|
AR123701A1
(es)
|
2020-10-08 |
2023-01-04 |
Merck Sharp & Dohme |
Preparación de derivados de oxindol como nuevos inhibidores de la diacilglicerol o-aciltransferasa 2
|
|
IL310851A
(en)
|
2021-08-19 |
2024-04-01 |
Merck Sharp & Dohme Llc |
Compounds for the treatment of diseases associated with PCSK9 activity
|
|
KR20250025685A
(ko)
|
2022-06-15 |
2025-02-24 |
머크 샤프 앤드 돔 엘엘씨 |
인터류킨-1 베타를 포획하기 위한 시클릭 펩티드
|
|
IL321166A
(en)
|
2022-12-02 |
2025-07-01 |
Merck Sharp & Dohme Llc |
Preparation of fused azole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors
|
|
WO2025106386A1
(en)
|
2023-11-14 |
2025-05-22 |
Merck Sharp & Dohme Llc |
A cyclic peptide for trapping interleukin-1 beta
|
|
WO2025128805A1
(en)
|
2023-12-15 |
2025-06-19 |
Merck Sharp & Dohme Llc |
A cyclic peptide il-1beta trap for the treatment of atherosclerosis and inflammatory disorders
|